Potential role for statins in the treatment of chronic HCV infection

Author： Zhu Qianqian Han Qunying Liu Zhengwen

ISSN： 1746-0794

Source： Future Virology, Vol.8, Iss.8, 2013-08, pp. : 727-729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The monoclonal antibody XTL 002 [HCV-AB68] has potential in the treatment of chronic hepatitis C virus (HCV) infection

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Alisporivir for the treatment of chronic HCV

By Azzaroli Francesco Turco Laura Lisotti Andrea Cecinato Paolo Calvanese Claudio Buonfiglioli Federica Cevenini Monica Montagnani Marco Mazzella Giuseppe

Future Virology, Vol. 7, Iss. 1, 2012-01 ,pp. : 9-18

Future Medicine

Access to resources Recommend Favorite

Antifibrogenic Therapies in Chronic HCV Infection

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 227-240

Bentham Science Publishers

Access to resources Recommend Favorite

Role of tenofovir in the treatment of chronic HBV infection

By van Böömmel Florian Berg Thomas

Future Virology, Vol. 3, Iss. 3, 2008-05 ,pp. : 207-220

Future Medicine

Access to resources Recommend Favorite

Statins a potential treatment for osteoporosis?

Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite